Physician Assistant · Lexington, KY
NPI
1407421688
Since 2021
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2195 Harrodsburg Rd
Lexington, KY, 40504
Phone (859) 323-2232
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
325 services
Medicare patients, 2024
118
Average age 66
Drug cost, 2024
$1.7M
3,588 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel E Hayes-Ueltschi was code 99214 (office e&m - established), 177 times for 98 patients. In total Rachel E Hayes-Ueltschi billed 325 services in 5 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 177 | 98 | $55.65 | $9,850 |
| 95251 Test - Miscellaneous | Office | 103 | 56 | $21.01 | $2,164 |
| 99215 Office E&M - Established | Office | 32 | 28 | $88.20 | $2,822 |
By year: 2022 $6,336 for 106 services; 2023 $16K for 308 services; 2024 $16K for 325 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel E Hayes-Ueltschi prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 365 prescriptions and refills. In total Rachel E Hayes-Ueltschi wrote 3,588 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 365 | 659 | 120 | $54K |
| Ozempic Semaglutide | 279 | 343 | 59 | $292K |
| Trulicity Dulaglutide | 262 | 332 | 52 | $307K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 251 | 505 | 117 | $23K |
| Metformin Hcl Generic | 199 | 479 | 74 | $1,236 |
| Jardiance Empagliflozin | 162 | 345 | 53 | $190K |
| Metformin Hcl Er Metformin Hcl | 140 | 313 | 50 | $2,269 |
| Mounjaro Tirzepatide | 133 | 145 | 28 | $141K |
| Novolog Flexpen Insulin Aspart | 122 | 193 | 46 | $27K |
| Humalog Kwikpen U-100 Insulin Lispro | 97 | 165 | 39 | $29K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 87 | 138 | 26 | $39K |
| Farxiga Dapagliflozin Propanediol | 80 | 158 | 23 | $86K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 69 | 114 | 31 | $25K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 56 | 117 | 19 | $4,947 |
| Levothyroxine Sodium Generic | 52 | 126 | 16 | $549 |
Brand drugs: 2,374 claims; generic drugs: 597 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rachel E Hayes-Ueltschi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.